Scar Treatment Market Size and Share Analysis by Treatment Type, Scar Type, End User - Global Industry Demand Forecast to 2030
주요 하이라이트
세계의 흉터 치료 시장은 2023년에 238억 달러, 2030년에는 528억 달러 규모에 달하며, 12.0% 이상의 CAGR로 성장합니다.
흉터 관리에 대한 인식 증가, 완벽한 피부에 대한 사람들의 관심 증가, 미용 성형에 대한 수요의 급증, 의료 기술의 발전으로 산업이 확대되고 있습니다.
레이저, 화학적 필링, 미세 박피술, 박피술 등 현재 이용 가능한 미용 수단이 개선되고 있습니다. 이러한 발전은 미적 감각을 향상시키기 위해 보다 효과적인 옵션을 제공할 수 있게 되었습니다.
시장 인사이트
북미는 2023년 약 37.8%의 점유율을 차지하며 가장 규모가 큰 지역으로 부상했습니다.
북미의 높은 가처분 소득과 이에 따른 퍼스널케어 제품에 대한 비용 증가가 이 지역의 산업을 지배하는 주요 요인입니다.
2023년 미국은 북미 산업에 가장 큰 기여를 하는 국가이며, 향후 10년간 더 빠른 CAGR로 발전할 가능성이 높습니다.
레이저 카테고리는 지난 10년간 12.7%로 가장 높은 성장률을 보일 것으로 보입니다. 이는 레이저 치료가 현재 사용 가능한 치료법보다 더 발전했기 때문입니다.
위축성 흉터와 여드름 흉터는 2023년 40.1%의 점유율로 업계에서 가장 큰 비중을 차지할 것으로 예상되며, 향후 10년간 가장 큰 비중을 차지할 것으로 보입니다.
켈로이드 및 비후성 흉터 카테고리는 향후 수년간 가장 빠른 CAGR로 성장할 것으로 예상됩니다. 이는 화상 및 외상 발생률과 함께 수술 건수가 증가하고 있기 때문입니다.
세계의 흉터 치료 시장을 분석했으며, 시장의 기본 구조·최신 상황 및 주요 촉진·억제요인, 세계 전체 및 지역별·주요 국가 시장 규모의 동향 전망(금액 기반, 2017-2030년), 치료 유형별·흉터 유형별·최종사용자별의 상세 동향, 현재의 시장 경쟁 상황, 주요 기업의 개요 등을 조사하여 전해드립니다.
목차
제1장 조사 범위
제2장 조사 방법
제3장 주요 요약
제4장 시장 지표
제5장 업계의 전망
- 시장 역학
- 동향
- 촉진요인
- 억제요인/과제
- 촉진요인/억제요인의 영향 분석
- 신종 코로나바이러스 감염증(COVID-19)의 영향
- Porter's Five Forces 분석
제6장 세계 시장
- 개요
- 시장 매출 : 치료 유형별(2017-2030년)
- 국소 치료 시장 매출 : 종류별(2017-2030년)
- 표면 치료 시장 매출 : 종류별(2017-2030년)
- 레이저 치료 시장 매출 : 종류별(2017-2030년)
- 주사 치료 시장 매출 : 종류별(2017-2030년)
- 시장 매출 : 흉터 유형별(2017-2030년)
- 시장 매출 : 최종사용자별(2017-2030년)
- 시장 매출 : 지역별(2017-2030년)
제7장 북미 시장
- 개요
- 시장 매출 : 치료 유형별(2017-2030년)
- 국소 치료 시장 매출 : 종류별(2017-2030년)
- 표면 치료 시장 매출 : 종류별(2017-2030년)
- 레이저 치료 시장 매출 : 종류별(2017-2030년)
- 주사 치료 시장 매출 : 종류별(2017-2030년)
- 시장 매출 : 흉터 유형별(2017-2030년)
- 시장 매출 : 최종사용자별(2017-2030년)
- 시장 매출 : 국가별(2017-2030년)
제8장 유럽 시장
제9장 아시아태평양 시장
제10장 라틴아메리카 시장
제11장 중동 및 아프리카 시장
제12장 미국 시장
- 개요
- 시장 매출 : 치료 유형별(2017-2030년)
- 국소 치료 시장 매출 : 종류별(2017-2030년)
- 표면 치료 시장 매출 : 종류별(2017-2030년)
- 레이저 치료 시장 매출 : 종류별(2017-2030년)
- 주사 치료 시장 매출 : 종류별(2017-2030년)
- 시장 매출 : 흉터 유형별(2017-2030년)
- 시장 매출 : 최종사용자별(2017-2030년)
제13장 캐나다 시장
제14장 독일 시장
제15장 프랑스 시장
제16장 영국 시장
제17장 이탈리아 시장
제18장 스페인 시장
제19장 일본 시장
제20장 중국 시장
제21장 인도 시장
제22장 호주 시장
제23장 한국 시장
제24장 브라질 시장
제25장 멕시코 시장
제26장 사우디아라비아 시장
제27장 남아프리카공화국 시장
제28장 아랍에미리트(UAE) 시장
제29장 경쟁 구도
- 시장 참여 기업과 제공 품목 리스트
- 주요 기업의 경쟁 벤치마킹
- 주요 기업의 제품 벤치마킹
- 최근 전략 개발 상황
제30장 기업 개요
- Avita Medical Inc.
- Revitol Corporation
- Sonoma Pharmaceuticals Inc.
- Molnlycke Health Care AB
- CCA Industries Inc.
- Sisram Medical Ltd.
- Biodermis
- Candela Corporation
- Smith & Nephew plc
- Scarguard Labs LLC
제31장 부록
KSA
Key Highlights
The scar treatment market generated a value of USD 23.8 billion in 2023, which will rise to USD 52.8 billion, advancing at over 12.0% CAGR, by 2030.
The rising consciousness regarding scar management, increasing interest of people in having flawless skin, surging need for cosmetic procedures, and evolving medical technology are aiding the industry expansion.
Individuals with long-term disfigurement due to burns, accidents, surgery, or other reasons are searching for effective means to improve their appearance.
The development of different therapies that decrease the scar's visibility and improve the overall skin texture has been enabled by the improvements in medical technology.
The improved cosmetic measures now accessible comprise lasers, chemical peels, microdermabrasion, and dermabrasion.
These advancements have made it possible to offer less intrusive as well as more effective choices to individuals for improving their aesthetics.
There has been an increasing acceptance of scar revision solutions because of the rising consciousness about the different options of treatment accessible.
The public has profited from the information provided by plastic surgeons, skincare experts, and dermatologists about the benefits of under-trial and current skin treatments.
With the arrival of elective surgeries and medical tourism, the count of surgical measures is increasing at a significant pace. This means that now, more potential patients are searching for post-surgery scar treatment.
Market Insights
North America was the largest contributor to the industry in 2023, with a share of approximately 37.8%.
The high disposable salary in North America, which results in a rise in the expenses on personal care products, is a major contributor to the dominance of the regional industry.
In 2023, the U.S. was the largest contributor to the industry in North America, and it is likely to advance at a faster compound annual growth rate during this decade.
The laser category will advance at the highest rate, of 12.7%, during this decade. This will be because laser treatments are more advanced than the currently accessible topical therapies.
Atrophic and acne scars accounted for the largest share of the industry in 2023, with a 40.1% share, and it will remain the largest throughout this decade.
Acne is among of the most common dermatological conditions globally, particularly among adolescents.
Acne occurs because of the clogging of the hair follicles in the skin with sebum, dirt, oil, dead skin cells, and various other impurities, which leads to lesions formation.
Approximately 9.4% of the global population suffers from acne, making it the 8th most prevalent illness in the world.
The keloid and hypertrophic scar category will propel at the fastest CAGR in the years to come. This will be because of the rising volume of surgeries, coupled with the incidence of burn injuries as well as traumatic wounds.
The scar treatment industry is moderately fragmented with the existence of some local players. Players in this industry are trying to enhance their presence by implementing strategies like mergers & acquisitions, partnerships, and investments.
The industry players are also concentrating on sustaining competitive pricing and investing in developing greater and more effective products.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by treatment type
- 1.4.2. Market size breakdown, by scar type
- 1.4.3. Market size breakdown, by end user
- 1.4.4. Market size breakdown, by region
- 1.4.5. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. Global Market
- 6.1. Overview
- 6.2. Market Revenue, by Treatment Type (2017-2030)
- 6.2.1. Topical market revenue, by type (2017-2030)
- 6.2.2. Surface market revenue, by type (2017-2030)
- 6.2.3. Laser market revenue, by type (2017-2030)
- 6.2.4. Injectable market revenue, by type (2017-2030)
- 6.3. Market Revenue, by Scar Type (2017-2030)
- 6.4. Market Revenue, by End User (2017-2030)
- 6.5. Market Revenue, by Region (2017-2030)
Chapter 7. North America Market
- 7.1. Overview
- 7.2. Market Revenue, by Treatment Type (2017-2030)
- 7.2.1. Topical market revenue, by type (2017-2030)
- 7.2.2. Surface market revenue, by type (2017-2030)
- 7.2.3. Laser market revenue, by type (2017-2030)
- 7.2.4. Injectable market revenue, by type (2017-2030)
- 7.3. Market Revenue, by Scar Type (2017-2030)
- 7.4. Market Revenue, by End User (2017-2030)
- 7.5. Market Revenue, by Country (2017-2030)
Chapter 8. Europe Market
- 8.1. Overview
- 8.2. Market Revenue, by Treatment Type (2017-2030)
- 8.2.1. Topical market revenue, by type (2017-2030)
- 8.2.2. Surface market revenue, by type (2017-2030)
- 8.2.3. Laser market revenue, by type (2017-2030)
- 8.2.4. Injectable market revenue, by type (2017-2030)
- 8.3. Market Revenue, by Scar Type (2017-2030)
- 8.4. Market Revenue, by End User (2017-2030)
- 8.5. Market Revenue, by Country (2017-2030)
Chapter 9. APAC Market
- 9.1. Overview
- 9.2. Market Revenue, by Treatment Type (2017-2030)
- 9.2.1. Topical market revenue, by type (2017-2030)
- 9.2.2. Surface market revenue, by type (2017-2030)
- 9.2.3. Laser market revenue, by type (2017-2030)
- 9.2.4. Injectable market revenue, by type (2017-2030)
- 9.3. Market Revenue, by Scar Type (2017-2030)
- 9.4. Market Revenue, by End User (2017-2030)
- 9.5. Market Revenue, by Country (2017-2030)
Chapter 10. LATAM Market
- 10.1. Overview
- 10.2. Market Revenue, by Treatment Type (2017-2030)
- 10.2.1. Topical market revenue, by type (2017-2030)
- 10.2.2. Surface market revenue, by type (2017-2030)
- 10.2.3. Laser market revenue, by type (2017-2030)
- 10.2.4. Injectable market revenue, by type (2017-2030)
- 10.3. Market Revenue, by Scar Type (2017-2030)
- 10.4. Market Revenue, by End User (2017-2030)
- 10.5. Market Revenue, by Country (2017-2030)
Chapter 11. MEA Market
- 11.1. Overview
- 11.2. Market Revenue, by Treatment Type (2017-2030)
- 11.2.1. Topical market revenue, by type (2017-2030)
- 11.2.2. Surface market revenue, by type (2017-2030)
- 11.2.3. Laser market revenue, by type (2017-2030)
- 11.2.4. Injectable market revenue, by type (2017-2030)
- 11.3. Market Revenue, by Scar Type (2017-2030)
- 11.4. Market Revenue, by End User (2017-2030)
- 11.5. Market Revenue, by Country (2017-2030)
Chapter 12. U.S. Market
- 12.1. Overview
- 12.2. Market Revenue, by Treatment Type (2017-2030)
- 12.2.1. Topical market revenue, by type (2017-2030)
- 12.2.2. Surface market revenue, by type (2017-2030)
- 12.2.3. Laser market revenue, by type (2017-2030)
- 12.2.4. Injectable market revenue, by type (2017-2030)
- 12.3. Market Revenue, by Scar Type (2017-2030)
- 12.4. Market Revenue, by End User (2017-2030)
Chapter 13. Canada Market
- 13.1. Overview
- 13.2. Market Revenue, by Treatment Type (2017-2030)
- 13.2.1. Topical market revenue, by type (2017-2030)
- 13.2.2. Surface market revenue, by type (2017-2030)
- 13.2.3. Laser market revenue, by type (2017-2030)
- 13.2.4. Injectable market revenue, by type (2017-2030)
- 13.3. Market Revenue, by Scar Type (2017-2030)
- 13.4. Market Revenue, by End User (2017-2030)
Chapter 14. Germany Market
- 14.1. Overview
- 14.2. Market Revenue, by Treatment Type (2017-2030)
- 14.2.1. Topical market revenue, by type (2017-2030)
- 14.2.2. Surface market revenue, by type (2017-2030)
- 14.2.3. Laser market revenue, by type (2017-2030)
- 14.2.4. Injectable market revenue, by type (2017-2030)
- 14.3. Market Revenue, by Scar Type (2017-2030)
- 14.4. Market Revenue, by End User (2017-2030)
Chapter 15. France Market
- 15.1. Overview
- 15.2. Market Revenue, by Treatment Type (2017-2030)
- 15.2.1. Topical market revenue, by type (2017-2030)
- 15.2.2. Surface market revenue, by type (2017-2030)
- 15.2.3. Laser market revenue, by type (2017-2030)
- 15.2.4. Injectable market revenue, by type (2017-2030)
- 15.3. Market Revenue, by Scar Type (2017-2030)
- 15.4. Market Revenue, by End User (2017-2030)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Revenue, by Treatment Type (2017-2030)
- 16.2.1. Topical market revenue, by type (2017-2030)
- 16.2.2. Surface market revenue, by type (2017-2030)
- 16.2.3. Laser market revenue, by type (2017-2030)
- 16.2.4. Injectable market revenue, by type (2017-2030)
- 16.3. Market Revenue, by Scar Type (2017-2030)
- 16.4. Market Revenue, by End User (2017-2030)
Chapter 17. Italy Market
- 17.1. Overview
- 17.2. Market Revenue, by Treatment Type (2017-2030)
- 17.2.1. Topical market revenue, by type (2017-2030)
- 17.2.2. Surface market revenue, by type (2017-2030)
- 17.2.3. Laser market revenue, by type (2017-2030)
- 17.2.4. Injectable market revenue, by type (2017-2030)
- 17.3. Market Revenue, by Scar Type (2017-2030)
- 17.4. Market Revenue, by End User (2017-2030)
Chapter 18. Spain Market
- 18.1. Overview
- 18.2. Market Revenue, by Treatment Type (2017-2030)
- 18.2.1. Topical market revenue, by type (2017-2030)
- 18.2.2. Surface market revenue, by type (2017-2030)
- 18.2.3. Laser market revenue, by type (2017-2030)
- 18.2.4. Injectable market revenue, by type (2017-2030)
- 18.3. Market Revenue, by Scar Type (2017-2030)
- 18.4. Market Revenue, by End User (2017-2030)
Chapter 19. Japan Market
- 19.1. Overview
- 19.2. Market Revenue, by Treatment Type (2017-2030)
- 19.2.1. Topical market revenue, by type (2017-2030)
- 19.2.2. Surface market revenue, by type (2017-2030)
- 19.2.3. Laser market revenue, by type (2017-2030)
- 19.2.4. Injectable market revenue, by type (2017-2030)
- 19.3. Market Revenue, by Scar Type (2017-2030)
- 19.4. Market Revenue, by End User (2017-2030)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Revenue, by Treatment Type (2017-2030)
- 20.2.1. Topical market revenue, by type (2017-2030)
- 20.2.2. Surface market revenue, by type (2017-2030)
- 20.2.3. Laser market revenue, by type (2017-2030)
- 20.2.4. Injectable market revenue, by type (2017-2030)
- 20.3. Market Revenue, by Scar Type (2017-2030)
- 20.4. Market Revenue, by End User (2017-2030)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Revenue, by Treatment Type (2017-2030)
- 21.2.1. Topical market revenue, by type (2017-2030)
- 21.2.2. Surface market revenue, by type (2017-2030)
- 21.2.3. Laser market revenue, by type (2017-2030)
- 21.2.4. Injectable market revenue, by type (2017-2030)
- 21.3. Market Revenue, by Scar Type (2017-2030)
- 21.4. Market Revenue, by End User (2017-2030)
Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Market Revenue, by Treatment Type (2017-2030)
- 22.2.1. Topical market revenue, by type (2017-2030)
- 22.2.2. Surface market revenue, by type (2017-2030)
- 22.2.3. Laser market revenue, by type (2017-2030)
- 22.2.4. Injectable market revenue, by type (2017-2030)
- 22.3. Market Revenue, by Scar Type (2017-2030)
- 22.4. Market Revenue, by End User (2017-2030)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Market Revenue, by Treatment Type (2017-2030)
- 23.2.1. Topical market revenue, by type (2017-2030)
- 23.2.2. Surface market revenue, by type (2017-2030)
- 23.2.3. Laser market revenue, by type (2017-2030)
- 23.2.4. Injectable market revenue, by type (2017-2030)
- 23.3. Market Revenue, by Scar Type (2017-2030)
- 23.4. Market Revenue, by End User (2017-2030)
Chapter 24. Brazil Market
- 24.1. Overview
- 24.2. Market Revenue, by Treatment Type (2017-2030)
- 24.2.1. Topical market revenue, by type (2017-2030)
- 24.2.2. Surface market revenue, by type (2017-2030)
- 24.2.3. Laser market revenue, by type (2017-2030)
- 24.2.4. Injectable market revenue, by type (2017-2030)
- 24.3. Market Revenue, by Scar Type (2017-2030)
- 24.4. Market Revenue, by End User (2017-2030)
Chapter 25. Mexico Market
- 25.1. Overview
- 25.2. Market Revenue, by Treatment Type (2017-2030)
- 25.2.1. Topical market revenue, by type (2017-2030)
- 25.2.2. Surface market revenue, by type (2017-2030)
- 25.2.3. Laser market revenue, by type (2017-2030)
- 25.2.4. Injectable market revenue, by type (2017-2030)
- 25.3. Market Revenue, by Scar Type (2017-2030)
- 25.4. Market Revenue, by End User (2017-2030)
Chapter 26. Saudi Arabia Market
- 26.1. Overview
- 26.2. Market Revenue, by Treatment Type (2017-2030)
- 26.2.1. Topical market revenue, by type (2017-2030)
- 26.2.2. Surface market revenue, by type (2017-2030)
- 26.2.3. Laser market revenue, by type (2017-2030)
- 26.2.4. Injectable market revenue, by type (2017-2030)
- 26.3. Market Revenue, by Scar Type (2017-2030)
- 26.4. Market Revenue, by End User (2017-2030)
Chapter 27. South Africa Market
- 27.1. Overview
- 27.2. Market Revenue, by Treatment Type (2017-2030)
- 27.2.1. Topical market revenue, by type (2017-2030)
- 27.2.2. Surface market revenue, by type (2017-2030)
- 27.2.3. Laser market revenue, by type (2017-2030)
- 27.2.4. Injectable market revenue, by type (2017-2030)
- 27.3. Market Revenue, by Scar Type (2017-2030)
- 27.4. Market Revenue, by End User (2017-2030)
Chapter 28. U.A.E. Market
- 28.1. Overview
- 28.2. Market Revenue, by Treatment Type (2017-2030)
- 28.2.1. Topical market revenue, by type (2017-2030)
- 28.2.2. Surface market revenue, by type (2017-2030)
- 28.2.3. Laser market revenue, by type (2017-2030)
- 28.2.4. Injectable market revenue, by type (2017-2030)
- 28.3. Market Revenue, by Scar Type (2017-2030)
- 28.4. Market Revenue, by End User (2017-2030)
Chapter 29. Competitive Landscape
- 29.1. List of Market Players and their Offerings
- 29.2. Competitive Benchmarking of Key Players
- 29.3. Product Benchmarking of Key Players
- 29.4. Recent Strategic Developments
Chapter 30. Company Profiles
- 30.1. Avita Medical Inc.
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. Revitol Corporation
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
- 30.3. Sonoma Pharmaceuticals Inc.
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. Molnlycke Health Care AB
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
- 30.5. CCA Industries Inc.
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. Sisram Medical Ltd.
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
- 30.7. Biodermis
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
- 30.8. Candela Corporation
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
- 30.9. Smith & Nephew plc
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary
- 30.10. Scarguard Labs LLC
- 30.10.1. Business overview
- 30.10.2. Product and service offerings
- 30.10.3. Key financial summary
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
